Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
completednot_applicable

OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.

NCT05844566
recruiting

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

NCT06726889
completednot_applicable

Proof of Concept Study of EMBalance Decision Support System to Evaluate Balance Disorders

NCT02704819

Clinical Trials (3)

Showing 3 of 3 trials
NCT05844566Not Applicable

OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.

Completed
NCT06726889

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

Recruiting
NCT02704819Not Applicable

Proof of Concept Study of EMBalance Decision Support System to Evaluate Balance Disorders

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3